Dr Nicola McMeekin

  • Research Associate (Health Economics & Health Technology Assessment)

telephone: 0141 330 5010
email: Nicola.Mcmeekin@glasgow.ac.uk
pronouns: She/her/hers

HEHTA, School of Health & Wellbeing,, Room 359, Clarice Pears Building, 90 Byres Road, Glasgow, G12 8TB

Import to contacts

Biography

I worked as an accountant for 20 years before studying on the HTA MSc run by HEHTA at the University of Glasgow in 2013.  During the summer break of the MSc I worked at the Health Economics Group at Newcastle University on a lung transplantation clinical trial. After completing the MSc in 2015 I began working for HEHTA as a Research Assistant working mainly on economic evaluations alongside clinical trials. Clinical trials I have worked on while at HEHTA include interventions for adults with intellectual disabilities and depression, treatment to reduce COPD exacerbations, lung cancer screening and financial incentives for encouraging smoking cessation in pregnant women. I also work on feasibility studies assessing the acceptability and feasibility of collecting data for economic evaluations, for example digital health interventions and behavioural interventions for people with severe intellectual disabilities. I have recently worked on other study types, building models to estimate cost-effectiveness; including estimating the cost-effectiveness of implementing a smoke-free policy in Scottish prisons.

My PhD proposed a new role for conceptual models in economic evaluations; using them to further investigate clinical trial data, particularly when results are uncertain.

 

 

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016
Number of items: 30.

2024

Gillooly, A. et al. (2024) Behavioural activation for depressive symptoms in adults with severe to profound intellectual disabilities: modelling and initial feasibility study. Journal of Applied Research in Intellectual Disabilities, 37(2), e13197. (doi: 10.1111/jar.13197) (PMID:38356379)

2023

McMeekin, N. et al. (2023) Implementation of a national smoke-free prison policy: an economic evaluation within the Tobacco in Prisons (TIPs) study. Tobacco Control, 32(6), pp. 701-708. (doi: 10.1136/tobaccocontrol-2021-056991) (PMID:35256533) (PMCID:PMC7615232)

Melville, C.A. et al. (2023) Predictors and moderators of the response of adults with intellectual disabilities and depression to behavioural activation and guided self-help therapies. Journal of Intellectual Disability Research, 67(10), pp. 986-1002. (doi: 10.1111/jir.13063) (PMID:37344986)

Mcmeekin, N., Sinclair, L., Robinson-Smith, L., Mitchell, A., Bauld, L., Tappin, D. M. and Boyd, K. A. (2023) Financial incentives for quitting smoking in pregnancy: are they cost-effective. Addiction, 118(8), pp. 1445-1456. (doi: 10.1111/add.16176) (PMID:36843417)

2022

Tappin, D. et al. (2022) Effect of financial voucher incentives provided with UK stop smoking services on the cessation of smoking in pregnant women (CPIT III): pragmatic, multicentre, single blinded, phase 3, randomised controlled trial. British Medical Journal, 379, e071522. (doi: 10.1136/bmj-2022-071522) (PMID:36261162) (PMCID:PMC9580214)

Gumley, A. I. et al. (2022) The EMPOWER blended digital intervention for relapse prevention in schizophrenia: a feasibility cluster randomised controlled trial in Scotland and Australia. Lancet Psychiatry, 9(6), pp. 477-486. (doi: 10.1016/S2215-0366(22)00103-1)

Gumley, A. I. et al. (2022) Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT. Health Technology Assessment, 26(27), (doi: 10.3310/hlze0479) (PMID:35639493) (PMCID:PMC9376801)

Cotton, S. et al. (2022) Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS). Trials, 23, 307. (doi: 10.1186/s13063-022-06226-8) (PMID:35422024) (PMCID:PMC9009490)

Hunt, K. et al. (2022) Process and impact of implementing a smoke-free policy in prisons in Scotland: TIPs mixed-methods study. Public Health Research, 10(1), (doi: 10.3310/WGLF1204) (PMID:35129938)

2021

Tweed, E. J. et al. (2021) Evaluation of a national smoke-free prisons policy using medication dispensing: an interrupted time-series analysis. Lancet Public Health, 6(11), e795-e804. (doi: 10.1016/S2468-2667(21)00163-8) (PMID:34537108) (PMCID:PMC8554387)

Too, E., Hastie, C. E. , McMeekin, N., Lucas, G. and Tappin, D. M. (2021) Are financial incentives effective and cost-effective in a ‘real life’ smoking cessation program for pregnant women? A phase IV ‘before and after’ study to provide evidence to secure long-term funding. Journal of Womens Health and Reproductive Medicine, 5(4), 17.

Sullivan, F. et al. (2021) Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging. European Respiratory Journal, 57(1), 2000670. (doi: 10.1183/13993003.00670-2020) (PMID:32732334)

2020

Mcmeekin, N., Sinclair, L., Bauld, L., Tappin, D. M. , Mitchell, A. and Boyd, K. A. (2020) A protocol for the economic evaluation of the Smoking Cessation in Pregnancy Incentives Trial (CPIT III). BMJ Open, 10, e038827. (doi: 10.1136/bmjopen-2020-038827)

McMeekin, N., Wu, O. , Germeni, E. and Briggs, A. (2020) How methodological frameworks are being developed: evidence from a scoping review. BMC Medical Research Methodology, 20, 173. (doi: 10.1186/s12874-020-01061-4) (PMID:32605535) (PMCID:PMC7325096)

Sinclair, L. et al. (2020) The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial. Trials, 21, 183. (doi: 10.1186/s13063-019-4042-8) (PMID:32059684) (PMCID:PMC7023794)

McMeekin, N., Geue, C. , Briggs, A. , Rombach, I., Li, H. K., Bejon, P., McNally, M., Atkins, B. L., Ferguson, J. and Scarborough, M. (2020) Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial. Wellcome Open Research, 4, 108. (doi: 10.12688/wellcomeopenres.15314.4)

Gumley, A. et al. (2020) Early signs monitoring to prevent relapse in psychosis and promote well-being, engagement, and recovery: protocol for a feasibility cluster randomized controlled trial harnessing mobile phone technology blended with peer support. JMIR Research Protocols, 9(1), e15058. (doi: 10.2196/15058) (PMID:31917372)

2019

Hunt, K. et al. (2019) Smoke-free prison policy development, implementation, and impact across the entire national prison service in Scotland (TIPs study): a three-phase, mixed methods natural experimental evaluation. Lancet, 394(S2), S15. (doi: 10.1016/S0140-6736(19)32812-0)

Scarborough, M. et al. (2019) Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT. Health Technology Assessment, 23(38), (doi: 10.3310/hta23380)

Devereux, G. et al. (2019) Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT. Health Technology Assessment, 23(37), pp. 1-146. (doi: 10.3310/hta23370)

McMeekin, N., Chrysos, A. E., Vale, L. and Fisher, A. J. (2019) Incorporating ex-vivo lung perfusion into the UK adult lung transplant service: an economic evaluation and decision analytic model. BMC Health Services Research, 19, 326. (doi: 10.1186/s12913-019-4154-6) (PMID:31117992)

Li, H.-K. et al. (2019) Oral versus intravenous antibiotics for bone and joint infection. New England Journal of Medicine, 380(5), pp. 425-436. (doi: 10.1056/NEJMoa1710926) (PMID:30699315)

2018

Devereux, G. et al. (2018) Effect of theophylline as adjunct to inhaled corticosteroids on exacerbations in patients with COPD: a randomized clinical trial. JAMA: Journal of the American Medical Association, 320(15), pp. 1548-1559. (doi: 10.1001/jama.2018.14432) (PMID:30326124) (PMCID:PMC6233797)

Jahoda, A. et al. (2018) Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT. Health Technology Assessment, 22(53), (doi: 10.3310/hta22530) (PMID:30265239)

Price, D.B. et al. (2018) Use of 'Low-Dose' Theophylline to Reduce Exacerbations of COPD: a Pragmatic Multicentre Randomised Placebo Controlled Trial. ATS 2018 International Conference, San Diego, CA, USA, 18-23 May 2018.

2017

Jahoda, A. et al. (2017) Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: a randomised controlled trial. Lancet Psychiatry, 4(12), pp. 909-919. (doi: 10.1016/S2215-0366(17)30426-1) (PMID:29153873) (PMCID:PMC5714593)

McMeekin, N., Briggs, A. and Wu, O. (2017) Developing A Conceptual Modelling Framework For Economic Evaluation. ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017. A754-A755. (doi: 10.1016/j.jval.2017.08.2120)

Scarborough, M. et al. (2017) Oral versus intravenous antibiotics for the treatment of bone and joint infection (OVIVA): a multicentre randomised controlled trial. 36th Annual Meeting of the European Bone and Joint Infection Society, Nantes, France, 7-9 Sep 2017.

2016

Fisher, A. et al. (2016) An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK. Health Technology Assessment, 20(85), pp. 1-276. (doi: 10.3310/hta20850) (PMID:27897967)

Wu, O. , McMeekin, N. and Hawkins, N. (2016) Lost in Translation: Randomised Controlled Trial and Systematic Review Evidence of Intracoronary Versus Intravenous Abciximab in St-Elevation Myocardial Infarction. ISPOR 19th Annual European Congress, Vienna, Austria, 29 Oct - 2 Nov 2016. A639. (doi: 10.1016/j.jval.2016.09.1685)

This list was generated on Wed Apr 17 13:39:35 2024 BST.
Jump to: Articles | Conference or Workshop Item
Number of items: 30.

Articles

Gillooly, A. et al. (2024) Behavioural activation for depressive symptoms in adults with severe to profound intellectual disabilities: modelling and initial feasibility study. Journal of Applied Research in Intellectual Disabilities, 37(2), e13197. (doi: 10.1111/jar.13197) (PMID:38356379)

McMeekin, N. et al. (2023) Implementation of a national smoke-free prison policy: an economic evaluation within the Tobacco in Prisons (TIPs) study. Tobacco Control, 32(6), pp. 701-708. (doi: 10.1136/tobaccocontrol-2021-056991) (PMID:35256533) (PMCID:PMC7615232)

Melville, C.A. et al. (2023) Predictors and moderators of the response of adults with intellectual disabilities and depression to behavioural activation and guided self-help therapies. Journal of Intellectual Disability Research, 67(10), pp. 986-1002. (doi: 10.1111/jir.13063) (PMID:37344986)

Mcmeekin, N., Sinclair, L., Robinson-Smith, L., Mitchell, A., Bauld, L., Tappin, D. M. and Boyd, K. A. (2023) Financial incentives for quitting smoking in pregnancy: are they cost-effective. Addiction, 118(8), pp. 1445-1456. (doi: 10.1111/add.16176) (PMID:36843417)

Tappin, D. et al. (2022) Effect of financial voucher incentives provided with UK stop smoking services on the cessation of smoking in pregnant women (CPIT III): pragmatic, multicentre, single blinded, phase 3, randomised controlled trial. British Medical Journal, 379, e071522. (doi: 10.1136/bmj-2022-071522) (PMID:36261162) (PMCID:PMC9580214)

Gumley, A. I. et al. (2022) The EMPOWER blended digital intervention for relapse prevention in schizophrenia: a feasibility cluster randomised controlled trial in Scotland and Australia. Lancet Psychiatry, 9(6), pp. 477-486. (doi: 10.1016/S2215-0366(22)00103-1)

Gumley, A. I. et al. (2022) Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT. Health Technology Assessment, 26(27), (doi: 10.3310/hlze0479) (PMID:35639493) (PMCID:PMC9376801)

Cotton, S. et al. (2022) Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS). Trials, 23, 307. (doi: 10.1186/s13063-022-06226-8) (PMID:35422024) (PMCID:PMC9009490)

Hunt, K. et al. (2022) Process and impact of implementing a smoke-free policy in prisons in Scotland: TIPs mixed-methods study. Public Health Research, 10(1), (doi: 10.3310/WGLF1204) (PMID:35129938)

Tweed, E. J. et al. (2021) Evaluation of a national smoke-free prisons policy using medication dispensing: an interrupted time-series analysis. Lancet Public Health, 6(11), e795-e804. (doi: 10.1016/S2468-2667(21)00163-8) (PMID:34537108) (PMCID:PMC8554387)

Too, E., Hastie, C. E. , McMeekin, N., Lucas, G. and Tappin, D. M. (2021) Are financial incentives effective and cost-effective in a ‘real life’ smoking cessation program for pregnant women? A phase IV ‘before and after’ study to provide evidence to secure long-term funding. Journal of Womens Health and Reproductive Medicine, 5(4), 17.

Sullivan, F. et al. (2021) Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging. European Respiratory Journal, 57(1), 2000670. (doi: 10.1183/13993003.00670-2020) (PMID:32732334)

Mcmeekin, N., Sinclair, L., Bauld, L., Tappin, D. M. , Mitchell, A. and Boyd, K. A. (2020) A protocol for the economic evaluation of the Smoking Cessation in Pregnancy Incentives Trial (CPIT III). BMJ Open, 10, e038827. (doi: 10.1136/bmjopen-2020-038827)

McMeekin, N., Wu, O. , Germeni, E. and Briggs, A. (2020) How methodological frameworks are being developed: evidence from a scoping review. BMC Medical Research Methodology, 20, 173. (doi: 10.1186/s12874-020-01061-4) (PMID:32605535) (PMCID:PMC7325096)

Sinclair, L. et al. (2020) The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial. Trials, 21, 183. (doi: 10.1186/s13063-019-4042-8) (PMID:32059684) (PMCID:PMC7023794)

McMeekin, N., Geue, C. , Briggs, A. , Rombach, I., Li, H. K., Bejon, P., McNally, M., Atkins, B. L., Ferguson, J. and Scarborough, M. (2020) Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial. Wellcome Open Research, 4, 108. (doi: 10.12688/wellcomeopenres.15314.4)

Gumley, A. et al. (2020) Early signs monitoring to prevent relapse in psychosis and promote well-being, engagement, and recovery: protocol for a feasibility cluster randomized controlled trial harnessing mobile phone technology blended with peer support. JMIR Research Protocols, 9(1), e15058. (doi: 10.2196/15058) (PMID:31917372)

Hunt, K. et al. (2019) Smoke-free prison policy development, implementation, and impact across the entire national prison service in Scotland (TIPs study): a three-phase, mixed methods natural experimental evaluation. Lancet, 394(S2), S15. (doi: 10.1016/S0140-6736(19)32812-0)

Scarborough, M. et al. (2019) Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT. Health Technology Assessment, 23(38), (doi: 10.3310/hta23380)

Devereux, G. et al. (2019) Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT. Health Technology Assessment, 23(37), pp. 1-146. (doi: 10.3310/hta23370)

McMeekin, N., Chrysos, A. E., Vale, L. and Fisher, A. J. (2019) Incorporating ex-vivo lung perfusion into the UK adult lung transplant service: an economic evaluation and decision analytic model. BMC Health Services Research, 19, 326. (doi: 10.1186/s12913-019-4154-6) (PMID:31117992)

Li, H.-K. et al. (2019) Oral versus intravenous antibiotics for bone and joint infection. New England Journal of Medicine, 380(5), pp. 425-436. (doi: 10.1056/NEJMoa1710926) (PMID:30699315)

Devereux, G. et al. (2018) Effect of theophylline as adjunct to inhaled corticosteroids on exacerbations in patients with COPD: a randomized clinical trial. JAMA: Journal of the American Medical Association, 320(15), pp. 1548-1559. (doi: 10.1001/jama.2018.14432) (PMID:30326124) (PMCID:PMC6233797)

Jahoda, A. et al. (2018) Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT. Health Technology Assessment, 22(53), (doi: 10.3310/hta22530) (PMID:30265239)

Jahoda, A. et al. (2017) Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: a randomised controlled trial. Lancet Psychiatry, 4(12), pp. 909-919. (doi: 10.1016/S2215-0366(17)30426-1) (PMID:29153873) (PMCID:PMC5714593)

Fisher, A. et al. (2016) An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK. Health Technology Assessment, 20(85), pp. 1-276. (doi: 10.3310/hta20850) (PMID:27897967)

Conference or Workshop Item

Price, D.B. et al. (2018) Use of 'Low-Dose' Theophylline to Reduce Exacerbations of COPD: a Pragmatic Multicentre Randomised Placebo Controlled Trial. ATS 2018 International Conference, San Diego, CA, USA, 18-23 May 2018.

McMeekin, N., Briggs, A. and Wu, O. (2017) Developing A Conceptual Modelling Framework For Economic Evaluation. ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017. A754-A755. (doi: 10.1016/j.jval.2017.08.2120)

Scarborough, M. et al. (2017) Oral versus intravenous antibiotics for the treatment of bone and joint infection (OVIVA): a multicentre randomised controlled trial. 36th Annual Meeting of the European Bone and Joint Infection Society, Nantes, France, 7-9 Sep 2017.

Wu, O. , McMeekin, N. and Hawkins, N. (2016) Lost in Translation: Randomised Controlled Trial and Systematic Review Evidence of Intracoronary Versus Intravenous Abciximab in St-Elevation Myocardial Infarction. ISPOR 19th Annual European Congress, Vienna, Austria, 29 Oct - 2 Nov 2016. A639. (doi: 10.1016/j.jval.2016.09.1685)

This list was generated on Wed Apr 17 13:39:35 2024 BST.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • A pilot randomised control trial of an intervention to reduce chicldren's exposure to second-hand smoke in the home in disadvantged communitites in Scotland
    Office of the Chief Scientific Adviser
    2023 - 2025
     
  • Healthy Dads Healthy Kids in Prisons: a feasibility study and pilot for a intervention to improve mental health and wellbeing and father-child relationships
    National Institute for Health Research
    2022 - 2024
     
  • A feasibility study to test the peer-led `A Stop Smoking In Schools Trial' intervention (ASSIST) in three culturally different middle income countries
    Medical Research Council
    2022 - 2025
     
  • Maximising the public health benefits of smokefree prisons
    National Institute for Health Research
    2021 - 2023
     

Teaching

Health Economics and Health Technology Assessment (HTA MSc) Module lead, week lead and tutor

HTA: Policy and Principles (HTA MSc) Week lead and tutor

Evaluating Costs in Digital Health Interventions (DHI MSc) Week lead 


Nicola resized for web